Navigation Links


vision at medicine technology

Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer

... 40 years ago, Bristol-Myers Squibb built aunified vision for the future of cancer treatment. With expertise,dedication and resolve, that vision led to the development of adiverse global portfolio of anti-cancer therapies that are animportant co...

MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions

...es should have regular eye exams. If youexperience vision problems, consult your doctor immediately. Veryrarely, some patients have experienced visual changes while takingACTOS. Please visit the ACTOS Web site at <a target="_blank" href="http://www.actos.com/">www.actos.com for Complete Prescribin...

Remicade Two Year Data in Ankylosing Spondylitis Show Improvement in Spinal Mobility and Spinal Inflammation

... to meet important medical needs.Schering-Plough's vision is to earn the trust of the physicians,patients and customers served by its approximately 33,500 peoplearound the world. The company is based in Kenilworth, N.J., and itsWeb site is <a target="_blank" href="http://www.schering-plough.com/">ww...

Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits

...ent in immune system function -- Improvement in vision -- Enhancement of male sexual function -- Improvement in the condition of the skin -- Increased level of energy and sense of overall well being The Pivotal 2005 Anti-Aging Trial was a double blind,placebo-controlled, 24 week study conducted...

Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid Arthritis Study

...to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians,patients and customers served by its approximately 33,500 peoplearound the world. The company is based in Kenilworth, N.J.,and its Web site is <a target="_blank" href="http://www.schering-plough.com/">w...

Treating Heart Disease Risk Factors May Slow Alzheimer's Disease Progression

...dementia through the promotion of brainhealth. Our vision is a world without Alzheimer's. For moreinformation, visit <a target="_blank" href="http://www.alz.org/">http://www.alz.org . -- Yan Deschaintre - Vascular Risk Factors Treatment May Slow Dementia Progression. (Funders: Fondation d...

Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death

...gularly. Very rarely, some people have experienced vision changesdue to swelling in the back of the eye while taking Avandia. CONTACT: US Media, Nancy Pekarek +1-215-751-7709, or Mary AnneRhyne,+1-919-483-2839, or Alice Hunt, +1-215-751-7709, UK Media,Phil Thomson,Joss Mathieson, or Gwenan White, +020-8047...

Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab

... 40 years ago, Bristol-Myers Squibb built aunified vision for the future of cancer treatment. With expertise,dedication and resolve, that vision led to the development of adiverse global portfolio of anti-cancer therapies that are animportant co...

Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival

... to meet important medical needs.Schering-Plough's vision is to earn the trust of the physicians,patients and customers served by its more than 33,500 people aroundthe world. The company's Web site is <a target="_blank" href="http://www.scheringplough.com/">www.scheringplough.com . Created in 1962, ...

Vision Deficit in Retinitis Pigmentosa Mice Corrected with DNA Nanoparticles

... WA. Mutations in genes important in the biologyof vision cause RP, a common genetic form of visual impairme...pies of genes into photoreceptor cells can correct vision defectsin RP," said Mark Cooper, M.D., Senior Vice President of Scienceand Medical Affairs. "In addi...

Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls

...histype. Tell your doctor if the child has blurred vision while usingDaytrana. Abuse of Daytrana can lead to dependence. Daytrana should be applied daily to clean, dry skin, which isfree of any cuts or irritation. Skin irritation or allergic skinrash may occur. For Full Prescribing Information go to <...

Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug Candidate, Sphingomab

...on), which contributes significantly toAMD-related vision loss. Lpath has demonstrated in previous studiesthat Sphingomab reduces scarring in a variety of organ systems byinhibiting S1P. "This is the first demonstration that S1P is a mediator of CNVin an AMD model," said Stoller, "and that antibody-mediate...

Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants

... infection (8.2 percent vs. 4 percent), andblurred vision (6.6 percent vs. 1.7 percent). About Major Depressive Disorder Major depressive disorder (MDD) is characterized by one or moremajor depressive episodes, (i.e., at least two weeks of depressedmood or loss of interest accompanied by at least four add...

Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting

... to meet important medical needs.Schering-Plough's vision is to earn the trust of the physicians,patients and customers served by its approximately 33,500 peoplearound the world. The company is based in Kenilworth, N.J., and itsWeb site is <a target="_blank" href="http://www.schering-plough.com/">ww...

VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual Meeting

...he VEGF Trap-Eye may offer thepotential to improve vision in patients with wet AMD with a regulardosing regi...tients with this condition can experience aloss of vision due to the development of abnormal, fragile bloodvessels in the back of the eye. A particular type o...

Lux Biosciences' Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007

... andunder-recognized medical condition that causes vision impairment,ocular pain, and loss of vision. Experts estimate that 10% of newU.S. cases of blindness result from this disease. Approximately300,000 people suffer from uveitis in the United States alone, themajority of whom are affected by anterior uve...

Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting

...muscle weakness, problems with cognition,speech or vision impairments. Approximately 80 percent of peoplewith MS experience some form of walking disability. Within 15 yearsof an MS diagnosis, 50 percent of patients often require assistancewalking and in later stages, about a third of patients are unableto w...

Schepens Scientists Identify Key to Integrating Transplanted Nerve Cells Into Injured Tissue

...ly make retinal transplantation and restoration of vision apossibility." He adds that transplantation of donor photoreceptors(in whole retina transplants) may prove to be more beneficial thantransplanting stem cells alone, as these retinal transplantscontain a complete organized supply of cells necessary fo...

Sirion Therapeutics Announces Clinical Data to be Presented at the 2007 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

...ne of the oldest, largest and mosthighly respected vision research organizations in the world,"stated Barry Butler, President and Chief Executive Officer ofSirion Therapeutics. "This is exciting news for our company in thatit is the first time we will be presenting scientific data on ourpipeline compounds. ...

Helix BioMedix to Discuss Potential of Its Proprietary Peptides at the BIO International Convention

...f advanced bioactive smallmolecule technology. Its vision is to be recognized as the worldleader in the identification, qualification and commercializationof natural and synthetic peptide technology. The company's core competencies include peptide design,synthesis and characterization together with assay d...

Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients

... 40 years ago, Bristol-Myers Squibb built aunified vision for the future of cancer treatment. With expertise,dedication and resolve, that vision led to the development of adiverse global portfolio of anti-cancer therapies that are animportant co...

Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C

...president,Schering-Plough Research Institute. "Our vision with PEGINTRON, ourcornerstone HCV therapy, and on... to meet important medical needs.Schering-Plough's vision is to earn the trust of the physicians,patients and customers served by its approximately 33,500 peo...

Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer

... 40 years ago, Bristol-Myers Squibb built aunified vision for the future of cancer treatment. With expertise,dedication and resolve, that vision led to the development of adiverse global portfolio of anti-cancer therapies that are animportant co...

Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

... 40 years ago, Bristol-Myers Squibb built aunified vision for the future of cancer treatment. With expertise,dedication and resolve, that vision led to the development of adiverse global portfolio of anti-cancer therapies that are animportant co...

Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

... 40 years ago, Bristol-Myers Squibb built aunified vision for the future of cancer treatment. With expertise,dedication and resolve, that vision led to the development of adiverse global portfolio of anti-cancer therapies that are animportant co...

Interferon Beta DNA Treatment Delivered with Ichor Technology Reduces Atherosclerosis Progression in Mice

... founded in 1921 by four renowned physicianswith a vision of providing outstanding patient care based upon theprinciples of cooperation, compassion and innovation. U.S. News& World Report consistently names Cleveland Clinic as one ofthe nation's best hospitals in its annual "America's BestHospitals" sur...

Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration

...he VEGF Trap-Eye may offer thepotential to improve vision in patients with wet AMD with dosingless frequentl...tic Retinopathy Study (ETDRS)chart. Maintenance of vision is defined as losing fewer than 3lines (equivalent to 15 letters) on the ETDRS chart. The interim a...

Cholesterol Drug Fails to Slow Progression of Coronary Disease, Cleveland Clinic Study Reports

... founded in 1921 by four renowned physicianswith a vision of providing outstanding patient care based upon theprinciples of cooperation, compassion and innovation. U.S. News& World Report consistently names Cleveland Clinic as one ofthe nation's best hospitals in its annual "America's BestHospitals" sur...

Media Advisory: ACC Updated Schedule

... to meet important medical needs.Schering-Plough's vision is to earn the trust of the physicians,patients and customers served by its approximately 33,500 peoplearound the world. The company is based in Kenilworth, N.J., and itsWeb site is <a target="_blank" href="http://www.schering-plough.com/">ww...

Schering-Plough Announces Presentation of Phase II Trial Results for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual Meeting of The American College of Cardiology/i2 Summit

... to meet important medical needs.Schering-Plough's vision is to earn the trust of the physicians,patients and customers served by its approximately 33,500 peoplearound the world. The company is based in Kenilworth, N.J., and itsWeb site is <a target="_blank" href="http://www.schering-plough.com/">ht...

Scottish Scientists Test ‘Secret Weapon’ Against Tumours

...h its partners and supporters,Cancer Research UK's vision is to beat cancer. - Cancer Research UKcarries out world-class research to improve understanding of thedisease and find out how to prevent, diagnose and treat differentkinds of cancer. - Cancer Research UK ensures that its findings areused to improve...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

...Technology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epit...
Other Contentsascosporesasexualasexualasexualasymmetryasymmetryatomatomatomatomatomattenuationattenuationauditoryauditoryauditoryauditory
(Date:9/5/2008)..., Blacksburg, Va. -- Innovative work on a new ...bourne, assistant professor of mechanical engineer...n Faculty Early Career Development (CAREER) award ...ch is the development of specific models and exper...equipped with a stent that has a unique type of in...
(Date:9/4/2008)...PHILADELPHIA Scientists at the M.D. Anderson Canc...ent for lung cancer specifically for African Ameri...tructive pulmonary disease (COPD), according to a ... Prevention Research, a journal of the American A...leagues analyzed data from 491 African Americans w...
(Date:9/4/2008)...A unique partnership between Syracuse University a...er access to life-saving vaccines for children liv...world. The Institute recently awarded $250,000 to...istant professor of chemistry in the College of Ar...nst tetanus and rotavirus, a severe form of diarrh...
(Date:9/4/2008)...Huntsville, Ala. -- A team including researchers a...y, together with colleagues from a number of other...alysis of genomic variation in the brain cancer gl...ancer Genome Atlas (TCGA) research network, a coll...titute and the National Human Genome Research Inst...
Breaking Biology News(10 mins):Goulbourne earns NSF award to research heart stent sensors 2Goulbourne earns NSF award to research heart stent sensors 3African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease 2Syracuse University partners with Serum Institute of India to develop vaccines for children 2Syracuse University partners with Serum Institute of India to develop vaccines for children 3Syracuse University partners with Serum Institute of India to develop vaccines for children 4Collaboration between researchers yields more comprehensive portrait of brain cancer 2AspenBio Outlines Steps for FDA 510 28k 29 Clearance of AppyScore 28TM 29 the First Blood Based Screen Triage Test for Human Appendicitis 8857 1AspenBio Outlines Steps for FDA 510 28k 29 Clearance of AppyScore 28TM 29 the First Blood Based Screen Triage Test for Human Appendicitis 8857 2AspenBio Outlines Steps for FDA 510 28k 29 Clearance of AppyScore 28TM 29 the First Blood Based Screen Triage Test for Human Appendicitis 8857 3AspenBio Outlines Steps for FDA 510 28k 29 Clearance of AppyScore 28TM 29 the First Blood Based Screen Triage Test for Human Appendicitis 8857 4Human factors researchers test voting systems for seniors that can improve voting accuracy and speed 8855 1Human factors researchers test voting systems for seniors that can improve voting accuracy and speed 8855 2New research tools are too complex for easy answers researchers say 8852 1New research tools are too complex for easy answers researchers say 8852 2New research tools are too complex for easy answers researchers say 8852 3Study Sheds Light on Origins of Sudden Cardiac Death 8851 1Study Sheds Light on Origins of Sudden Cardiac Death 8851 2
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
Other TagspasspasspasspasspasslegleglegleglegleglegsuspectwalkwalkwalkreconstructiondrawdrawdrawOther Tagspalm 2stand 2stand 3stand 4stand 5stand 6stand 7stand 8stand 9stand 10morning 2simultaneously 2simultaneously 3simultaneously 4simultaneously 5simultaneously 6simultaneously 7